Urothelial carcinoma, locally advanced or metastatic
Oncology 4 drugs · 7 brands available in Jordan
Drugs used for Urothelial carcinoma, locally advanced or metastatic
| Drug | Class |
|---|---|
| Atezolizumab | L01X - Other antineoplastic agents |
| Avelumab | L01F - Monoclonal antibodies and antibody drug conjugates |
| Durvalumab | L10X - L10X |
| Nivolumab | L01X - Other antineoplastic agents |
Brands (7)
| Brand | Form / strength | Agent | Citizen (JOD) |
|---|---|---|---|
| Opdivo | Injection 40 mg/4 ml | ORIENT DRUG STORE CO | — |
| Opdivo | Injection 100 mg/10 ml | ORIENT DRUG STORE CO | — |
| Tecentriq | Vial 1200 mg/20 ml | Shawi & Rushedat Drug Store | — |
| Imfinzi | Vial 120 mg/2.4 ml | Shawi & Rushedat Drug Store | — |
| Imfinzi | Vial 500 mg/10 ml | Shawi & Rushedat Drug Store | — |
| Bavencio | Vial 20 mg/1 ml | Nabulsi Drug Store | — |
| Tecentriq SC 1875mg/15ML solution for injection | Powder for Injection Atezolizumab 1875 mg | Shawi & Rushedat Drug Store | — |